review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Phillip C. Wright | Q30505784 |
P2093 | author name string | Jules A Westbrook | |
Josselin Noirel | |||
Janet E Brown | |||
Caroline A Evans | |||
P2860 | cites work | Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents | Q29547450 |
Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies | Q33688759 | ||
Susceptibility to COPD: differential proteomic profiling after acute smoking | Q33921450 | ||
Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability | Q34149563 | ||
Tandem Mass Tags: A Novel Quantification Strategy for Comparative Analysis of Complex Protein Mixtures by MS/MS | Q34192662 | ||
Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions | Q34279143 | ||
iTRAQ underestimation in simple and complex mixtures: "the good, the bad and the ugly". | Q35002931 | ||
Gas-phase purification enables accurate, multiplexed proteome quantification with isobaric tagging | Q35488768 | ||
MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics | Q35491186 | ||
Statistical considerations of optimal study design for human plasma proteomics and biomarker discovery | Q35873957 | ||
Protein biomarker discovery and validation: the long and uncertain path to clinical utility | Q36561644 | ||
Design and analysis issues in quantitative proteomics studies | Q36950957 | ||
Review of software tools for design and analysis of large scale MRM proteomic datasets | Q37177456 | ||
Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development | Q37714579 | ||
Banking of clinical samples for proteomic biomarker studies: a consideration of logistical issues with a focus on pre-analytical variation | Q37817290 | ||
An insight into iTRAQ: where do we stand now? | Q37997372 | ||
Isobaric tagging approaches in quantitative proteomics: the ups and downs | Q38009633 | ||
Opportunities for protein interaction network-guided cellular engineering | Q38071034 | ||
Label-free quantification in clinical proteomics | Q38097312 | ||
Comparison of label-free and label-based strategies for proteome analysis of hepatoma cell lines. | Q39108916 | ||
A critical assessment of feature selection methods for biomarker discovery in clinical proteomics | Q41894005 | ||
Addressing accuracy and precision issues in iTRAQ quantitation | Q42427843 | ||
Western blots versus selected reaction monitoring assays: time to turn the tables? | Q42595907 | ||
Candidate verification of iron-regulated Neisseria meningitidis proteins using isotopic versions of tandem mass tags (TMT) and single reaction monitoring | Q42634780 | ||
Statistical inference from multiple iTRAQ experiments without using common reference standards | Q42984757 | ||
Multiple reaction monitoring of mTRAQ-labeled peptides enables absolute quantification of endogenous levels of a potential cancer marker in cancerous and normal endometrial tissues | Q46481136 | ||
iTRAQ experimental design for plasma biomarker discovery | Q47639363 | ||
Hyperplex-MRM: a hybrid multiple reaction monitoring method using mTRAQ/iTRAQ labeling for multiplex absolute quantification of human colorectal cancer biomarker | Q47874059 | ||
Technical, experimental, and biological variations in isobaric tags for relative and absolute quantitation (iTRAQ). | Q51075678 | ||
General statistical framework for quantitative proteomics by stable isotope labeling. | Q51113887 | ||
Systematic comparison of label-free, metabolic labeling, and isobaric chemical labeling for quantitative proteomics on LTQ Orbitrap Velos. | Q51467338 | ||
Comparative analysis to guide quality improvements in proteomics. | Q51772108 | ||
Proteomics meets the scientific method. | Q55056925 | ||
Report from the Wellcome Trust/EBA “Perspectives in Clinical Proteomics” retreat - A strategy to implement Next-Generation Proteomic Analyses to the clinic for patient benefit: Pathway to translation | Q56444472 | ||
P433 | issue | 3-4 | |
P921 | main subject | biomarker | Q864574 |
P304 | page(s) | 295-300 | |
P577 | publication date | 2015-02-10 | |
P1433 | published in | Proteomics - Clinical Applications | Q15754475 |
P1476 | title | Quantitation with chemical tagging reagents in biomarker studies | |
P478 | volume | 9 |
Q47421750 | Analysis of the plasma proteome using iTRAQ and TMT-based Isobaric labeling |
Q61816784 | Application of Proteomics to Inflammatory Bowel Disease Research: Current Status and Future Perspectives |
Q26774743 | Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology |
Q55293538 | Comprehensive mass spectrometry based biomarker discovery and validation platform as applied to diabetic kidney disease. |
Q52725521 | Designing Successful Proteomics Experiments. |
Q57821720 | Identification of Candidate Biomarkers in Malignant Ascites from Patients with Hepatocellular Carcinoma by iTRAQ-Based Quantitative Proteomic Analysis |
Q57058181 | Mass spectrometry-based proteomics techniques and their application in ovarian cancer research |
Q52687355 | Novel proteins that regulate cell extension formation in fibroblasts. |
Q58779295 | Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias |
Q47729926 | Proteomic analysis of mitochondria: biological and clinical progresses in cancer |
Q52662413 | Proteomic analysis of plasma from rheumatoid arthritis patients with mild cognitive impairment. |
Q92510792 | Proteomics and Bioinformatics Analysis of Cartilage in Post-Traumatic Osteoarthritis in a Mini-Pig Model of Anterior Cruciate Ligament Repair |
Q50984144 | Science is 1% inspiration and 99% biomarkers. |
Q38447411 | Spermatogenesis-associated proteins at different developmental stages of buffalo testicular seminiferous tubules identified by comparative proteomic analysis |
Q38785881 | Taking the stock of granule cargo: Platelet releasate proteomics |
Search more.